Heterogeneity Analysis of 18F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting

被引：29

作者：

Budiawan H. ^{[1
,2
]}

Cheon G.J. ^{[1
,3
,4
]}

Im H.-J. ^{[1
]}

Lee S.J. ^{[1
]}

Paeng J.C. ^{[1
]}

Kang K.W. ^{[1
,3
]}

Chung J.-K. ^{[1
]}

Lee D.S. ^{[1
]}

机构：

[1] Department of Nuclear Medicine, Seoul National University Hospital, Seoul

[2] Department of Nuclear Medicine, Mochtar Riady Comprehensive Cancer Centre, Siloam Hospitals Semanggi, Jakarta

[3] Cancer Research Institute, Seoul National University, Seoul

[4] Department of Nuclear Medicine, Seoul National University College of Medicine, Jongro-gu, Seoul, 110-744

来源：

Nuclear Medicine and Molecular Imaging | 2013年 / 47卷 / 4期

关键词：

Adenocarcinoma of the lung; Heterogeneity; Lymph node metastasis; Positron emission tomography (PET);

D O I：

10.1007/s13139-013-0216-6

中图分类号：

学科分类号：

摘要：

Purpose: Lymph node (LN) characterization is crucial in determining the stage and treatment decisions in patient with lung cancer. Although 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) has a higher diagnostic accuracy in LN characterization than anatomical imaging, differentiating between metastatic and inflammatory LNs is still challenging because both could show high 18F-FDG uptake. The purpose of this study was to assess if the heterogeneity of the 18F-FDG uptake could help in differentiating between inflammatory and metastatic LNs in lung cancer, and to compare with other parameters. Methods: A total of 44 patients with adenocarcinoma of the lung, who underwent preoperative 18F-FDG PET/CT without having any previous treatments and were revealed to have 18F-FDG-avid LNs, were enrolled. There were 52 pathology-proven metastatic lymph nodes in 26 subjects. The pathology-proven metastatic LNs were compared with 42 pathology-proven inflammatory/benign LNs in 18 subjects. The coefficient of variation (CV) was used to assess the heterogeneity of 18F-FDG uptake by dividing the standard deviation of standardized uptake value (SUV) by mean SUV. The volume of interest was manually drawn based on the combined CT images of 18F-FDG PET/CT (no threshold is used). Comparisons were made with the maximum standardized uptake values (SUVmax), visual assessment of 18F-FDG uptake, longest diameter, and maximum Hounsfield units (HUmax). Results: Metastatic lymph nodes tended to have higher CVs than the inflammatory LNs. The mean CV of metastatic LNs (0.30 ± 0.08; range: 0.08-0.55) was higher than that of inflammatory LNs (0.17 + 0.06; range, 0.07-0.32; P < 0.0001). On receiver operating characteristic (ROC) curve analysis, the area under curve was 0.901, and using 0.20 as cut-off value, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were 88.5 %, 76.2 %, 82.2 %, 84.3, and 83.0 % respectively. Accuracy of CV was slightly higher than SUVmax and diameter, but significantly higher than visual assessment and HUmax. Conclusions: In patients with adenocarcinoma of the lung having no prior treatments, metastatic LNs showed more heterogeneous 18F-FDG uptake than inflammatory LNs. Measuring the CV of the SUV derived from a manual volume of interest (VOI) can be helpful in determining metastatic LN of adenocarcinoma of the lung. Including diagnostic criteria of CV into the diagnostic approach can increase the accuracy of mediastinal node status. © 2013 Korean Society of Nuclear Medicine.

引用

页码：232 / 241

页数：9

共 39 条

[1]

Pieterman R.M., van Putten J.W., Meuzelaar J.J., Mooyaart E.L., Vaalburg W., Koeter G.H., Et al., Preoperative staging of non-small cell lung cancer with positron-emission tomography, N Eng J Med., 343, pp. 254-261, (2000)

[2]

De Leyn P., Vansteenkiste J., Cuypers P., Deneffe G., van Raemdonck D., Coosemans W., Et al., Role of cervical mediastinoscopyin staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan, Eur J Cardiothorac Surg, 12, pp. 706-712, (1997)

[3]

Fischer B., Lassen U., Morten J., Larsen S., Loft A., Bertelsen A., Et al., Preoperative staging of lung cancer with combined PET-CT, N Eng J Med, 361, pp. 32-39, (2009)

[4]

Perigaud C., Bridji B., Roussel J.C., Sagan C., Mugniot A., Duveau D., Et al., Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer, Eur J Cardiothorac Surg, 36, pp. 731-736, (2009)

[5]

Yang W., Fu Z., Yu J., Yuan S., Zhang B., Li D., Et al., Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer, Lung Cancer, 61, 1, pp. 35-43, (2008)

[6]

Warburg O., Wind F., Negelein E., The metabolism of tumors in the body, J Gen Physiol, 8, pp. 519-530, (1927)

[7]

Chung J.H., Cho K.J., Lee S.S., Baek H.J., Park J.H., Cheon G.J., Et al., Overexpression of Glut1 in lymphoid follicles correlates with false-positive <sup>18</sup>F-FDG PET results in lung cancer staging, J Nucl Med, 45, pp. 999-1003, (2004)

[8]

Kubota R., Kubota K., Yamada S., Tada M., Ido T., Tamahashi N., Active and passive mechanisms of [fluorine-18]fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: A microautoradiographic study, J Nucl Med, 35, pp. 1067-1075, (1994)

[9]

Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., Ido T., Intratumoral distribution of fluorine-18-fluorodeoxyglucosein vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography, J Nucl Med, 33, pp. 1972-1980, (1992)

[10]

Brown R.S., Leung J.Y., Fisher S.J., Frey K.A., Ethier S.P., Whal R.L., Intratumoral distribution of tritiatedfluorodeoxyglucose in breast carcinoma. I. Are inflammatory cells important?, J Nucl Med, 36, pp. 1854-1861, (1995)

← 1 2 3 4 →